The Einstein Aging Study has received a $32 million grant from the National Institutes of Health (NIH) to…
Articles by Margarida Maia, PhD
A dual vaccine targeting both amyloid plaques and tangled fibers made up of tau — two abnormal protein aggregates that…
Aduhelm (aducanumab) continues to clear away amyloid plaques and tangled fibers made up of tau — two abnormal protein…
AEV103 (3,6’-dithiopomalidomide), a potentially immunomodulating medicine, was able to quell brain inflammation and slow cognitive decline in a mouse model…
Seelos Therapeutics is gearing up for a pilot study, in Australia, testing SLS-005 (trehalose) — its investigational therapy for…
A first patient has joined the Tau NexGen study that will test two antibodies in combination — targeting both amyloid…
Cassava Sciences has launched a new website, called Rethink-ALZ.com, to make it easier for anyone interested to access information…
Lecanemab, an investigational antibody also known as BAN2401, has been granted a fast track designation from the U.S. Food…
Biogen and Eisai are stepping up their Phase 4 post-marketing confirmatory study to verify that Aduhelm (aducanumab) is…
Altoida is starting a five-year study to feed its app-based Precision Neurology device with data from thousands of…